Redsenol-1 Plus Officially Recognized by the National Cancer Institute
Significant Progress in Botanical Therapeutics
Canada Royal Enoch Phytomedicine Ltd., a pioneer in ginseng and ginsenoside research, is thrilled to announce that its innovative supplement, Redsenol-1 Plus Noble Ginsenosides, has achieved a remarkable milestone. This ginsenoside supplement has been incorporated into the National Cancer Institute's (NCI) Drug Dictionary. This recognition emphasizes Canada Royal Enoch Phytomedicine's dedication to enhancing cancer research while highlighting the potential of Redsenol-1 Plus in oncology and supportive care.
Understanding the NCI Drug Dictionary Listing
The NCI Drug Dictionary serves as an outstanding reference for the definitions and synonyms of drugs and agents used for treating cancer and its related conditions. With its recent definition, Redsenol-1 Plus is now categorized as "an oral and herbal supplement containing sixteen ginsenosides derived from ginseng, including rarer monomer forms like Rg3(R, S), Rh1(S, R), and others..." This unique categorization underlines the diverse range of ginsenosides present in Redsenol-1 Plus.
The Unique Features of Redsenol-1 Plus
What sets Redsenol-1 Plus apart from typical ginseng supplements is its composition. Most ginseng extracts primarily provide a smaller range of large-molecule, less absorbable ginsenosides such as Rg1, Rb1, Rd, Re, and Rc. In contrast, Redsenol-1 Plus has a remarkable mix of sixteen bioactive and easily absorbable rare ginsenosides, with a concentration of 20%. This percentage significantly exceeds those of conventional ginseng supplements, which usually only reach about 4% total ginsenosides.
Technological Advances in Ginsenoside Extraction
Canada Royal Enoch Phytomedicine has developed proprietary technologies for the extraction, processing, transformation, and formulation of rare ginsenosides. These state-of-the-art techniques enable the large-scale production of these beneficial compounds, significantly enhancing the company's position as a global leader in ginsenoside innovation and setting it apart from the competition.
Commitment to Research and Scientific Advancement
“The inclusion of Redsenol-1 Plus in the NCI Drug Dictionary offers researchers a standardized definition of its components,” expressed Dr. Peihua Yu, founder and CEO of Canada Royal Enoch Phytomedicine. “We are committed to advancing the scientific understanding of ginsenoside applications in conditions related to cancer through thorough research.”
Ongoing Clinical Trials with Redsenol-1 Plus
In alignment with the recognition from the NCI, Canada Royal Enoch Phytomedicine is also conducting clinical trials aimed at evaluating Redsenol-1 Plus’s effectiveness in addressing cancer-related fatigue—a common and disruptive symptom faced by patients undergoing treatment. This meticulous, triple-blind, placebo-controlled study is being executed by KGK Science, Inc., a prestigious clinical research organization based in Canada. The success of this trial may not only boost understanding of Redsenol-1 Plus but also shape it as a pivotal solution to alleviate cancer-related fatigue.
About Canada Royal Enoch Phytomedicine Ltd.
Canada Royal Enoch Phytomedicine Ltd. stands at the forefront of biotechnology, specializing in the research, production, and sale of natural, plant-based health solutions. The flagship product line, Redsenol (also known as Redsenol-1, Redsenol-1 Plus, and Redsenol DAG), features high-concentration ginsenoside supplements comprising various rare ginsenosides. Through its unique extraction, transformation, and formulation technologies, Canada Royal Enoch Phytomedicine seeks to unlock the complete potential of ginseng and ginsenosides for health and well-being.
Frequently Asked Questions
What is Redsenol-1 Plus?
Redsenol-1 Plus is an oral herbal supplement featuring sixteen ginsenosides derived from ginseng, noted for its potential benefits in cancer care.
How does Redsenol-1 Plus differ from other ginseng products?
Unlike many ginseng extracts that contain low amounts of active ingredients, Redsenol-1 Plus offers a higher concentration of rare and absorbable ginsenosides, making it significantly more effective.
What are the implications of being listed in the NCI Drug Dictionary?
The NCI Drug Dictionary listing provides researchers with an official definition of Redsenol-1 Plus's components, promoting further studies and applications in cancer research.
Is there ongoing research related to Redsenol-1 Plus?
Yes, Canada Royal Enoch is conducting clinical trials to assess the efficacy of Redsenol-1 Plus in mitigating cancer-related fatigue, aiming to provide substantial evidence for its benefits.
Where can I find more information about Canada Royal Enoch Phytomedicine?
For additional details on Canada Royal Enoch Phytomedicine and its product offerings, you can visit their official website.
